Meeting
2024 ASCO Genitourinary Cancers Symposium
Systemic and surgical treatment in renal cell carcinoma: Does timing matter?
Authors
Konstantin Egon Seitzer
Department of Urology and Pediatric Urology, West German Cancer Center, University Hospital Münster, Münster, Germany
Konstantin Egon Seitzer , Christopher Darr , Thomas Hilser , Andres Jan Schrader , Linda Huberth , Anne Mausbach , Martin Janssen , Laura-Maria Krabbe , Barbara Heitplatz , Boris A. Hadaschik , Martin Boegemann , Katrin Schlack , Viktor Grünwald
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 417)
DOI
10.1200/JCO.2024.42.4_suppl.417
Abstract #
417
Poster Bd #
G20
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Phase II study of cabozantinib (Cabo) with nivolumab (Nivo) and ipilimumab (Ipi) in advanced renal cell carcinoma with variant histologies (RCCvh).
First Author: Bradley Alexander McGregor
Poster
2023 ASCO Annual Meeting
Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).
First Author: Aaron Scott Mansfield
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.
First Author: Jianbo Wang
Poster
2022 ASCO Annual Meeting
Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).
First Author: Aaron Scott Mansfield